Insight & Intelligence

More »

GEN Podcasts

The Sounds of Science podcast is brought to you by GEN. Listen as members of the editorial team—Editor-in-Chief John Sterling, Technical Editor Jeff Buguliskis, and Senior News Editor Alex Philippidis—showcase innovative research, new initiatives, and important policy by interviewing thought-leaders, eminent life-science researchers, and company leaders. These short, but informative podcasts will keep you up-to-date with the latest and most important life science advances.

February 22, 2017

Seeking Young Scientists for Research in Space

Nicole M. Nichols, Ph.D., group leader for DNA amplification development at New England Biolabs, discusses the third national Genes in Space competition. The winner will have his or her experiment carried out aboard the International Space Station.

February 16, 2017

Sorting Out the CRISPR Patent Case

Bill Warren, partner with the law firm Eversheds Sutherland and chair of its biotechnology and life sciences team, discusses the ruling by a three-judge panel of the Patent Trial and Appeal Board siding with the Broad Institute of MIT and Harvard in the bitter legal battle over who invented CRISPR (clustered regularly interspaced short palindromic repeats) gene-editing technology.

February 2, 2017

“Sexual Attraction” Neurons in the Brain Discovered

Finding in female mice may also be relevant to certain human psychiatric disorders.

January 30, 2017

Best Practices for Closing the Gender Gap

Jodie Morrison, CEO and President of Tokai Pharmaceuticals, is one of nearly 200 biopharma leaders who recently signed an open letter endorsing a Top Ten of best practices for advancing gender diversity, from the boardroom to the C-suite to the lab.

January 17, 2017

When the Pressure Is High the Dementia Is Low

Findings from a new study suggest that the onset of high blood pressure later in life is associated with lower dementia risk after age 90. Listen now for more details!

January 10, 2017

Taking on the Multi-Drug-Resistant Bacteria Challenge

Entasis Therapeutics is working on novel therapies for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients.

January 9, 2017

What Trump Will Mean for Biomedical Research

Benjamin Corb, public affairs director for the American Society for Biochemistry and Molecular Biology (ASBMB), discusses what the biomedical research community can expect from the incoming administration of Donald J. Trump.

December 22, 2016

All I Want for Christmas Is A Mind Controlled Toy!

The next generation of toys could be controlled by the power of the mind, thanks to researchers at the University of Warwick who have recently developed electronic devices to be activated using electrical impulses from brain waves, by connecting our thoughts to computerized systems.

December 14, 2016

Would You Want to Know Your Future Alzheimer's Status?

A new survey led by researchers at Stanford University School of Medicine asked a representative group of adults 65 and older, how willing they would be to learn about their possible cognitive decline. Listen now for more details!

December 9, 2016

The Promise of ‘Cures’ for Drug Research and Development

Jay Jackson, manager with Avalere Health, discusses the 21st Century Cures Act, which recently passed both houses of Congress by overwhelming majorities. The measure has long been championed by supporters as a vehicle for speeding up approval of new drugs and maintaining U.S. leadership in research. Critics say the bill does too much for big pharma and not enough for patients seeking relief from rising drug prices.

November 30, 2016

Smelly Camel Urine Finding Could Lead to Novel Therapies for Sleeping Sickness

Scientists in Ireland have solved a mystery regarding the cause of especially smelly camel urine. Their research has implications for the millions of people affected by African parasites called trypanosomes, which frequently cause death from sleeping sickness.

November 17, 2016

A New Clinic Focused on Cancer Immunotherapy

David G. Maloney, M.D., Ph.D., of the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance, discusses the new Bezos Family Immunotherapy Clinic, a first-of-its-kind facility focused on providing cancer immunotherapies to patients.

November 15, 2016

The Heartbreaking Effects of Marijuana

Findings from a new retrospective study has found that active marijuana use could increase the risk for developing a rare cardiovascular event.

October 31, 2016

Third Extinct Human Ancestor DNA Found in Pacific Islanders

A new computer analysis from investigators at the MD Anderson Cancer Center suggests that traces of long-lost human cousins may be buried in modern people’s DNA.

October 24, 2016

Amid Election Clamor, Research Issues Surface

Mary Woolley, President of Research!America, which advocates for medical and health research funding, discusses key issues in research that the next president is likely to confront. How can researchers keep those issues on the national agenda no matter who wins on Election Day?

October 17, 2016

Probiotics Help Save the Spine

A new study from investigators at The Ohio State University entitled “Gut dysbiosis impairs recovery after spinal cord injury,” describes the impact the gut microbiome has on spinal cord injury and how probiotics could help speed recovery.

October 3, 2016

Look Beyond the Lab For That Next Job

One area where biopharma employment has been increasing is in regulatory affairs and compliance.

September 22, 2016

Four-Stranded DNA May Aid in Developing Targeted Cancer Therapies

Quadruple helices appear to have role in switching genes on or off.

September 12, 2016

Feed a Cold, Starve a Fever: Old World Wisdom Still Holds True

Yale University researchers have uncovered the intriguing mechanisms that underlie common sickness behaviors.

April 15, 2013

BIO 2013 Session Preview: “Behind the Tech Transfer Headlines”

Interview with Jon Soderstrom, Ph.D., managing director of the office of cooperative research at Yale University and moderator of the BIO tech transfer session, and Atul Saran, senior vp of corporate development and ventures at MedImmune